Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Autor: Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.; Department of Mathematics, University of Ioannina, Ioannina, Greece., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Parker H; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laidou S; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Catherwood M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Kotaskova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Benito R; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Bonfiglio S; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Scarfo L; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Davis Z; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Gogia A; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Rani L; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rapado I; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Miras F; Hospital Universitario 12 Octubre, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., de la Serna J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Rivas JMH; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Thornton P; Haematology Department, Beaumont Hospital, Dublin, Ireland., Larráyoz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Calasanz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Fésüs V; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Mátrai Z; Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Gupta R; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bosch F; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tazón-Vega B; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Baran-Marszak F; Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France., Oscier D; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Nguyen-Khac F; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Terol MJ; Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain., Cuneo A; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Strefford JC; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Ghia P; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.

Publikováno v: Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 504.

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.

Autor: Janusz K; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Izquierdo MM; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Cadenas FL; Hematología, Hospital Universitario de Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain., Ramos F; Hematología, Hospital Universitario de León, León, Spain., Sánchez JMH; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Lumbreras E; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Robledo C; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Del Real JS; Hematología, Hospital Universitario de León, León, Spain., Caballero JC; Hematología, Hospital Universitario de Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain., Collado R; Hematología, Hospital General Universitario de Valencia, Valencia, Spain., Bernal T; Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain., Pedro C; Hematología, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, Spain., Insunza A; Hematología, Hospital Universitario Marqués de Valdecilla, Santander, Spain., de Paz R; Hematología, Hospital Universitario de la Paz, Madrid, Spain., Xicoy B; Hematología, Hospital Universitari Germans Trias I Pujol, Instituto Catalán de Oncología (ICO), Badalona, Spain., Salido E; Hospital Universitario de Canarias, Universidad La Laguna, San Cristóbal de La Laguna, Spain., García JS; Hematología, Hospital Universitario Reina Sofía, Córdoba, Spain., Mínguez SS; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., García CM; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Muñoz AMS; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Barba MS; Departamento de Estadística, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain., Rivas JMH; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Hematología, Hospital Universitario de Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain., Abáigar M; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Campelo MD; Hematología, Hospital Universitario de Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain. mdiezcampelo@usal.es.

Publikováno v: Annals of hematology [Ann Hematol] 2021 Aug; Vol. 100 (8), pp. 1995-2004. Date of Electronic Publication: 2021 Jan 06.